L-arginine
- Generic Name
- L-arginine
- Brand Names
- Clinimix 2.75/5
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 74-79-3
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy of Aspirin and L-arginine in High Risk Preeclamptic
- Conditions
- Interventions
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2020-11-27
- Lead Sponsor
- University of Guadalajara
- Target Recruit Count
- 82
- Registration Number
- NCT02838030
- Locations
- 🇲🇽
Antiguo Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
Arginine Therapy for Sickle Cell Disease Pain
- Conditions
- Interventions
- First Posted Date
- 2015-08-31
- Last Posted Date
- 2023-09-06
- Lead Sponsor
- Emory University
- Target Recruit Count
- 108
- Registration Number
- NCT02536170
- Locations
- 🇺🇸
Children's Healthcare of Atlanta at Hugh Spalding, Atlanta, Georgia, United States
🇺🇸Children's Healthcare of Atlanta at Scottish Rite, Atlanta, Georgia, United States
🇺🇸Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia, United States
Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin
- First Posted Date
- 2015-08-05
- Last Posted Date
- 2015-08-07
- Lead Sponsor
- University Hospital, Basel, Switzerland
- Target Recruit Count
- 5
- Registration Number
- NCT02516085
L-arginine and Brown Adipose Tissue
- Conditions
- Interventions
- First Posted Date
- 2014-11-14
- Last Posted Date
- 2014-11-14
- Lead Sponsor
- Maastricht University Medical Center
- Target Recruit Count
- 26
- Registration Number
- NCT02291458
- Locations
- 🇳🇱
Maastricht University Medical Center +, Maastricht, Limburg, Netherlands
L-arginine in Severe Asthma Patients Grouped by Exhaled Nitric Oxide Levels
- First Posted Date
- 2013-04-26
- Last Posted Date
- 2020-04-21
- Lead Sponsor
- Nicholas Kenyon
- Target Recruit Count
- 54
- Registration Number
- NCT01841281
- Locations
- 🇺🇸
UC Davis CTSC Clinical Research Center, Sacramento, California, United States
L-arginine Therapy on Endothelium-dependent Vasodilation & Mitochondrial Metabolism in MELAS Syndrome
- First Posted Date
- 2012-05-22
- Last Posted Date
- 2013-12-17
- Lead Sponsor
- The Hospital for Sick Children
- Target Recruit Count
- 7
- Registration Number
- NCT01603446
- Locations
- 🇨🇦
The Hospital for Sick Children, Toronto, Ontario, Canada
Prospective L-arginine Study
- First Posted Date
- 2011-12-05
- Last Posted Date
- 2017-01-10
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 3
- Registration Number
- NCT01485757
- Locations
- 🇺🇸
University of Michigan Pediatric Heart Transplant Clinic, Ann Arbor, Michigan, United States
Endothelial Facilitation in Alzheimer's Disease
- Conditions
- Interventions
- First Posted Date
- 2011-09-23
- Last Posted Date
- 2019-07-30
- Lead Sponsor
- University of Massachusetts, Worcester
- Target Recruit Count
- 11
- Registration Number
- NCT01439555
- Locations
- 🇺🇸
UMass Medical School/ UMass Memorial Medical Center, Worcester, Massachusetts, United States
Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids
- Conditions
- Interventions
- First Posted Date
- 2011-07-07
- Last Posted Date
- 2012-07-03
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 7
- Registration Number
- NCT01388764
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Effect of L-arginine and Glutamine on Preterm
- First Posted Date
- 2010-12-20
- Last Posted Date
- 2014-04-15
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 75
- Registration Number
- NCT01263041
- Locations
- 🇪🇬
NICU of Children hospital and Nicu of obstetric and gynecology hospital, ain shams university, Cairo, Egypt
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.